Corient Capital Partners, LLC Zoetis Inc. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 22,340 shares of ZTS stock, worth $3.96 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
22,340
Previous 22,232
0.49%
Holding current value
$3.96 Million
Previous $3.82 Million
0.5%
% of portfolio
0.29%
Previous 0.29%
Shares
16 transactions
Others Institutions Holding ZTS
# of Institutions
1,954Shares Held
419MCall Options Held
1.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.52 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.48 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.84 Billion2.73% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.67 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...